Introduction
============

Nuchal translucency (NT) measurement is an excellent and sensitive screening test for fetal chromosomal abnormalities. It is the sonographic appearance of subcutaneous accumulation of fluid behind the fetal neck in the first trimester of pregnancy. Possible causes for the development of this increased fluid-filled space include cardiac failure secondary to structural malformation, abnormalities in the extracellular matrix, and ahnormal or delayed development of the lymphatic system. Increased NT which is defined a NT measurement above the 95th centile ([@b1-ijph-41-92]) is found in 5% of the screened fetuses ([@b2-ijph-41-92]), of which the majorities are chromosomally and anatomically normal. The association of increased NT with chromosomal and nonchromosomal abnormalities has been studied for the past two decades ([@b2-ijph-41-92]--[@b7-ijph-41-92]). In addition, the prevalence of chromosomal defects and adverse pregnancy outcome (APO) including miscarriage, fetal loss, and fetal abnormalities increases exponentially with NT thickness ([@b8-ijph-41-92]). Despite of many studies, there is still uncertainty and concern about the outcome of fetuses with increased NT; this may cause severe anxiety in parents. In fact there is not a general agreement on how to counsel parents and diminish anxiety about fetal development.

In this study we aimed to evaluate the outcome of pregnancies with increased NT in our population in order to use in counseling.

Materials and Methods
=====================

This cross sectional study was performed at Iranian Fetal Medicine foundation (FMF) between January 2009 and December 2011 after approval by local Ethics Committee. Our study included 9746 pregnant women attending the clinic for routine first trimester screening. A computer search was carried out to identify all singleton pregnancies with crown--rump length of 45--84 mm and NT of ≥ 95th centile. The technique used to measure NT followed the guideline recommended by the UK Fetal Medicine Foundation ([@b1-ijph-41-92]). All cases were checked for nasal bone and examination of skull, brain, chest, abdominal wall, stomach, bladder and upper and lower extremities. Exclusion criteria were fetal aneuploidy, fetal major anomaly and multiple pregnancies. All examinations were performed transabdominal with a curvilinear 2--6MHz transducer,Aloka α-10 (Tokyo-Japan).The risk of fetal aneuploidy was calculated by astraia software. The screen positive cases were offered karyotyping. All cases with increased NT including those with normal karyotype were recommended follow-up scans at 18--20 weeks of gestation and fetal echocardiography at 20--24 weeks of gestations. All children were examined at birth by neonatologist or pediatrician. Karyotype was done by blood serum of neonates in suspected cases. Pregnancy outcome was obtained from delivery and nursery records and the patients themselves. The outcome was asked by telephone interviews with parents or the pediatrician whenever was necessary. The follow up period at the time of telephone interviews was ranged 2 months to more than 2 years. Normal karyotype was defined based on genetic testing or pediatric examination. The prevalence of adverse pregnancy outcome including miscarriage, hydrops, intrauterine death, fetal abnormalities diagnosed before or after delivery and termination of pregnancy including indicated and maternal request was recorded.

Results
=======

In this study from 9746 screened pregnant women with mean maternal age of 29.8 years (range from 15 to 46), 186 cases had NT≥ 95th centile at 11--14 weeks of gestation ([Fig. 1](#f1-ijph-41-92){ref-type="fig"}).

Nuchal translucency was between 2.4--14 mm with a median of 4.6 mm. There were 37(19.8%) cases of aneuploidy in the study population, including 29 cases of trisomy 21, three of trisomy 18, two of trisomy 13, three of Turner syndrome. The rate of abnormal chromosomal defects was increased with increasing NT thickness ([Table 1](#t1-ijph-41-92){ref-type="table"}).

There were 3 intra uterine fetal death (2 multiple anomaly, 1 unknown), 2 hydrops fetalis, 4 spontaneous fetal loss, 17 termination of pregnancy (TOP) for anxiety including 3 with normal karyotype. Fetal structural abnormalities were found in 13/149 (8.7%) on follow-up ultrasound examinations antenatally (7 cases) and postnatally (6 cases). The prevalence of fetal malformations was not proportional to the degree of NT thickness as shown in [Table 2](#t2-ijph-41-92){ref-type="table"}.

The most common fetal malformation was heart defects. Therefore 110 (77.8%) children with NT≥95th centile, normal serial scans, and normal echocardiography were born alive and were reported normal at birth and postnatal follow up ([Table 3](#t3-ijph-41-92){ref-type="table"}).

Discussion
==========

Approximately 20% of screened women in our study had abnormal karyotype that is in agreement with Kagan et al. ([@b9-ijph-41-92]) that used cut off 95th centile, but disagree with Bilardo et al. ([@b10-ijph-41-92]) who reported 33.8% abnormal karyotype with the same cut off. In a study the prevalence of abnormal karyotype was 44% ([@b11-ijph-41-92]) which was much higher than our study, this can be explained by considering different cut off for NT measurement by them. After exclusion of adverse pregnancy outcome, the chance of having a normal baby was 95%, this figure can be used in counseling of parents with increased NT in the future. Structural anomalies were detected in 8.7% of fetuses which is in agreement with another study ([@b12-ijph-41-92]) who reported 7.3% and Bilardo et al. ([@b13-ijph-41-92]) (6.3%) while in the study by senat et al. ([@b11-ijph-41-92]) the prevalence of fetal malformations was 26%, much higher than our rate, this maybe for including NT above 4 mm as cut off. The prevalence of fetal malformations was not proportional to the degree of NT thickness as shown in [Table 3](#t3-ijph-41-92){ref-type="table"}, this can be explained with higher rate of TOP based on maternal request in group with NT≥3.5, but the overall rate of APO was proportional to the degree of NT enlargement. Termination of pregnancy was done by 11.4% parents after first trimester screening due to anxiety and uncertainty of future outcome. These parents had rushed decision on TOP despite of 3 with normal karyotype; it seems limitation of termination of pregnancy to the age of less than 18 weeks in our country helps this decision. Besides, our defensive and cautiously counseling has exacerbated parental anxiety as Ville ([@b14-ijph-41-92]) clearly described the challenging of counseling in cases with increased NT.

Fortunately a recent review of article reported the rate of neurodevelopmental delay as 1% that is not much different from general population ([@b15-ijph-41-92]). Our study was not designed for this issue but according to parent's declaration and follow 2--3 years by the pediatricians, neurodevelopmental delay was not reported. The most common fetal malformation was heart defects that are in keeping with the other studies ([@b5-ijph-41-92], [@b16-ijph-41-92]--[@b19-ijph-41-92]). The prevalence of cardiac defects was 6 times higher in fetuses with NT above 99th centile in some studies ([@b19-ijph-41-92]--[@b21-ijph-41-92]), but our small sample size does not let us to draw any conclusion about heart defects. The spontaneous fetal loss rate of 4.6% in the fetuses with increased NT was in correspondence to Bilardo et al. ([@b13-ijph-41-92]).

Conclusion
==========

Our study showed that one out of four fetuses with enlarged NT had an adverse pregnancy outcome according to our definition for APO. Uncertainty and rushed decision on TOP falsely raised the rate of APO, as after exclusion of those with adverse outcome, the chance of having a normal outcome was found to be 95%, that is good information and new hope for counseling in the future. However, larger prospective studies with long-term follow -up and focus on neurodevelopmental delay with standard definition and standardized tools for delay are needed.
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###### 

Incidence of chromosomal defects according To nuchal translucency

  **Nuchal Translucency (mm)**   **Total number**   **Abnormal karyotype n (%)**
  ------------------------------ ------------------ ------------------------------
  95th centile- 3.4              92                 10(10)
  3.5--4.4                       50                 6(12)
  4.5--5.4                       12                 4(33)
  5.5--6.4                       15                 7(46)
  ≥ 6.5                          17                 10(58)
  Total                          186                37(19.8)

###### 

Pregnancy outcome of 149 fetuses with increased NT in relation to degree of NT enlargement

  **Adverse outcome \[n (%)\]**                                                      
  ------------------------------- ----- -------- -------- ------- -------- --------- ---------
  95th centile- 3.4               82    1(1)     0        9(10)   1(1)     11(13)    71(86)
  3.5--4.4                        43    2(4)     1(2)     2(4)    3(7)     7(16)     35(81)
  4.5--5.4                        7     0        0        1(14)   4(57)    5(57)     2(28)
  5.5--6.4                        8     3(37)    0        0       4(50)    7(87)     1(12)
  ≥ 6.5                           19    1(11)    1(11)    1(11)   5(55)    8(88)     1(11)
  Total                           149   7(4.6)   2(1.3)   13(8)   17(11)   39 (26)   110(74)

NT, nuchal translucency; APO, adverse pregnancy outcome; TOP, termination of pregnancy

###### 

Detailed outcome of 149 fetuses with NT≥95th

  ----------------------------------------------------------------------------------------------------------------------------------------
                              **Malformations detected antenatally**   **outcome**   **Malformations detected postnatally**   **NT(mm)**
  --------------------------- ---------------------------------------- ------------- ---------------------------------------- ------------
  Cardiac malformation        6                                                                                               

                              Tetralogy of Fallot&\                    TOP                                                    4.5
                              Ventriculomegaly& Renal agenesia                                                                

                              Tetralogy of Fallot & Dady- walker\      Delivery                                               3.4
                              Malformation& Polycystic kidney                                                                 

                              ASD & Limbs Anomaly                      TOP                                                    3

                                                                                     ASD                                      3.7

                                                                                     ASD                                      3

                                                                                     VSD                                      3.2

  Unirary tract Abnormality   2                                                                                               

                              Infantile polycystic Kidney              Delivery                                               3

                              Hydronephrosis                           Delivery                                               3.9

  Pulmonary defect            1                                                                                               3

                              Diaphragmatic hernia                     Delivery                                               3

  Gastrointestinal defects    2                                        Delivery      Hirschsprung disease                     3

                                                                       Delivery      Esophageal atresia                       7

  Skeletal defects            2                                                                                               

                              Akinesia deformation                     TOP                                                    3.1

                                                                       Delivery      Digit deformity                          3
  ----------------------------------------------------------------------------------------------------------------------------------------

TOP, termination of pregnancy; ASD, Atrial septal defect; VSD, ventricular septal defect
